MedPath

Community-based Precise Management for Patients With Coronary Artery Disease

Not Applicable
Conditions
Coronary Artery Disease
Interventions
Other: Community-based precise management
Other: Standard community-based management
Registration Number
NCT05344053
Lead Sponsor
Chinese Academy of Medical Sciences, Fuwai Hospital
Brief Summary

The community-based precise management for patients with coronary artery disease study is a prospective, cluster-randomized, open-labeled trial. The purpose of this trial is to test whether a community-based precise management and rehabilitation model under the hierarchical medical system could help improve the cardiovascular risk factors control in patients with coronary artery disease. Additionally, the trial will also evaluate the impact of the model on major cardiovascular adverse events in patients with coronary artery disease.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
480
Inclusion Criteria
  • Patients with prior myocardial infarction
  • or receiving percutaneous coronary intervention or coronary artery bypass graft;
  • or coronary artery stenosis≥50% defined by coronary angiography or coronary CT angiography
Exclusion Criteria
  • Refuse to sign the written informed consent;
  • Patients without the ability to take care of themselves;
  • Mental disorders;
  • Alcoholics or drug addicts;
  • Cannot be followed up for any reasons;
  • Life expectancy<1 year due to non-cardiovascular reasons.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Community-based precise managementCommunity-based precise management-
Standard community-based managementStandard community-based management-
Primary Outcome Measures
NameTimeMethod
Status of risk factors control of coronary artery disease1 year

A composite of not smoking, blood pressure\<140/90mmHg/\<130/80mmHg for patients with diabetes, HbA1c≤7%, LDL-C\<1.8mmol/L, antiplatelet therapy, and statins use.

Secondary Outcome Measures
NameTimeMethod
All-cause death1 year
Myocardial infarction1 year
Readmission1 year
Coronary revascularization1 year
Stroke1 year

Trial Locations

Locations (1)

Infirmary of Industrial and Commercial Bank of China

🇨🇳

Beijing, Beijing, China

© Copyright 2025. All Rights Reserved by MedPath